Provided by Tiger Trade Technology Pte. Ltd.

FUNDX FUTURE FUND OPPORTUNITIES ETF

28.70
+0.22500.79%
Volume:3K
Turnover:94.44K
Market Cap:233.72M
PE:- -
High:28.70
Open:28.66
Low:28.66
Close:28.47
52wk High:31.30
52wk Low:25.44
Shares:8.15M
Float Shares:8.15M
Volume Ratio:0.23
T/O Rate:0.04%
Dividend:0.50
Dividend Rate:1.73%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Halozyme CEO Helen Torley Disposes of 48,000 Common Shares Worth $5.31 Million

Reuters
·
Yesterday

Guardant announces Europe approval of Guardnat360 CDx as Etcamaha companion

TIPRANKS
·
Yesterday

Guardant Health Wins EU CE Mark for Guardant360 CDx as Camizestrant Companion Diagnostic in ER-Positive Breast Cancer

Reuters
·
Yesterday

Guardant Health Announces Approval in Europe of Guardant360® Cdx as Companion Diagnostic for AstraZeneca’s Etcamah™ (Camizestrant) in Advanced Er-Positive Breast Cancer

THOMSON REUTERS
·
Yesterday

Guardant Health to Report Q3 2026 Financial Results After Market Close, Host Conference Call

Reuters
·
Yesterday

Halozyme Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $130 from $115

THOMSON REUTERS
·
Oct 08

Does Patent Injunction Win Change The Bull Case For Halozyme Therapeutics (HALO)?

Simply Wall St.
·
Oct 08

Sector Update: Healthcare

MT Newswires Live
·
Oct 08

Merck's Keytruda is Dealt a Legal Setback. It's Good News for This Biotech Stock.

Dow Jones
·
Oct 08

U.S. Stocks on the MOVE-Halozyme, BKV, AppFolio

Reuters
·
Oct 08

Guardant Health is Maintained at Overweight by Barclays

Dow Jones
·
Oct 07

Halozyme Therapeutics Shares up 2% After Court Win Against Merck to Block Subcutaneous Keytruda in Select Markets

THOMSON REUTERS
·
Oct 07

Halozyme announces Dutch court of the Hague found Merck infringed patents

TIPRANKS
·
Oct 07

Halozyme Wins Dutch Court Injunction Blocking Merck Keytruda SC in Eight European Markets over EP622 Patent

Reuters
·
Oct 07

Halozyme Therapeutics - Iv Version of Keytruda Remains Available and not Covered by Halozyme's Patent or Court Injunction

THOMSON REUTERS
·
Oct 07

Halozyme Therapeutics - Court Rejects Merck's Arguments That Ep622 Patent is Invalid

THOMSON REUTERS
·
Oct 07

Halozyme Wins Injunction Stopping Manufacture and Sale of Merck's Keytruda Sc in Multiple European Markets

THOMSON REUTERS
·
Oct 07

Halozyme Therapeutics - Court Orders Msd BV to Stop Keytruda Sc Manufacture and Sale in Eight European Countries

THOMSON REUTERS
·
Oct 07

Halozyme Therapeutics - Injunction Forbids Msd from Facilitating Infringement by Affiliates

THOMSON REUTERS
·
Oct 07

Halozyme Expands Enhanze Collaboration with Argenx to Cover Two Additional Exclusive Targets

Reuters
·
Oct 07